Log in

Relevant bibliographies by topics / Diabetes Iran / Journal articles

Journal articles on the topic 'Diabetes Iran'

To see the other types of publications on this topic, follow the link: Diabetes Iran.

Author: Grafiati

Published: 10 December 2022

Last updated: 29 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Diabetes Iran.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Sanjari, Mahnaz, Maryam Aalaa, Mohammad Reza Amini, Neda Mehrdad, Hosein Adibi, Ensieh Nasli Esfahani, and Bagher Larijani. "Conceptual map of diabetes education: necessity of establishing iran diabetes academy." Journal of Diabetes & Metabolic Disorders 18, no. 2 (October 8, 2019): 729–31. http://dx.doi.org/10.1007/s40200-019-00441-y.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Mohammad Alavinia, Seyed, Koorosh Etemad, Alireza Mahdavi, Maryam Omidvar, Sara Imanpour, Rudmilla Rahman, Muhiuddin Haider, and Jared Frank. "Gestational diabetes mellitus in Iran – experience from the National Diabetes Program." International Journal of Pharmaceutical and Healthcare Marketing 6, no. 2 (June 22, 2012): 156–66. http://dx.doi.org/10.1108/17506121211243077.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Ozma, Mahdi Asghari, Jalil Rashedi, Behroz Mahdavi Poor, Ali Vegari, Vahid Asgharzadeh, Hossein Samadi Kafil, Abdolhassan Kazemi, Leyla Sahebi, and Mohammad Asgharzadeh. "Tuberculosis and Diabetes Mellitus in Northwest of Iran." Infectious Disorders - Drug Targets 20, no. 5 (December 9, 2020): 667–71. http://dx.doi.org/10.2174/1871526519666190715142100.

Full text

Abstract:

Background: Planning for control of tuberculosis would need to screen and identify individuals susceptible to TB. Due to the weakness of immune system in diabetic patients, it is more likely for them to reactivate latent TB infection. Regarding the increasing number of diabetics in the community, in this study efforts have been made to estimate the frequency of individuals who have tuberculosis and diabetes mellitus (TB-DM) simultaneously, as it could help making preventive decisions to reduce TB in this part of Iran. Materials and Methods: In this study, 329 cases of confirmed TB patients were divided into two groups of diabetic and non-diabetic, then demographic information and clinical variables have been compared between the two groups. Results: Among the examined subjects, 47 patients (14.29 %) had suffered from diabetes mellitus and tuberculosis. All of the DM patients had pulmonary tuberculosis and 87.23% of them were over the age of 50. Conclusion: : Majority of DM-TB patients were over 50 years of age and also more than half of them were women. So it seems that for DM women over the age of 50, to detect tuberculosis, screening tests such as PPD may be necessary.

APA, Harvard, Vancouver, ISO, and other styles

4

Pishdad, G. R. "Low Incidence of Type 1 Diabetes in Iran." Diabetes Care 28, no. 4 (March 25, 2005): 927–28. http://dx.doi.org/10.2337/diacare.28.4.927.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Beiranvand, Fatemeh, and Mohsen Alizadeh. "Plants for remedies of diabetes mellitus in Iran." Plant Biotechnology Persa 1, no. 1 (November 1, 2019): 36–38. http://dx.doi.org/10.29252/pbp.1.1.36.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Jafarvand, Elnaz, Amin Ataey, and Sare Edalati. "Epidemiology and Death Trends Due to Diabetes in Iran." Quarterly of the Horizon of Medical Sciences 27, no. 2 (April 1, 2021): 198–213. http://dx.doi.org/10.32598/hms.27.2.2764.1.

Full text

Abstract:

Aims: Diabetes mortality undergoes a growing trend worldwide that results in reducing life expectancy in society. Diabetes has been a significant health challenge in recent decades and imposed a lot of economic burden on the community. The present study aimed to evaluate the trend of diabetes mortality in Iran over five years. Methods & Materials: The mortality data published by the Ministry of Health and Medical Education has been used in this analytical cross-sectional study. The number and rate of diabetic cases are specified based on age, gender, location, and the death process from 2006 to 2010. Findings: About 54.9% and 45.1% of the deaths occurred in women and men, respectively, with a male to female ratio of 0.82. The highest death rate was observed in individuals aged above 70 and 50-69 years with an average age of 68.1 years. A higher mortality rate was observed in the cities than in the countryside, and 40% of deaths occurred due to non-insulin-dependent (type II) diabetes mellitus. Conclusion: Diabetes mortality has increased from 2006 to 2010. Higher deaths were observed in women and cities. Considering the increasing population of older adults in Iran, diabetes prevention and control interventions can be carried out through screening, planning, and education.

APA, Harvard, Vancouver, ISO, and other styles

7

Pishdad, G. R. "Age at Diagnosis of Non-Insulin-Dependent Diabetes Mellitus in Southern Iran." Journal of International Medical Research 23, no. 5 (September 1995): 381–85. http://dx.doi.org/10.1177/030006059502300509.

Full text

Abstract:

To obtain an estimate of the age at onset of non-insulin-dependent diabetes mellitus in southern Iran, the medical records of the confirmed diabetic patients who attended the diabetes and endocrine clinics in southern Iran from March 1984 to February 1993 were reviewed. The case records of 2566 patients, in whom non-insulin-dependent diabetes mellitus was considered most probable, and who were resident in southern Iran at the time of diagnosis, were studied; they included 1176 (45.8%) men and 1390 (54.2%) women. The age at diagnosis of the disease in men ranged between 18 and 82 years with a mean of 45.6 ± 11.4 (± SD) years, and in women, between 15 and 83 with a mean of 44.3 ± 12.2 (± SD) years. There was no statistically significant sex-related difference in the mean age at diagnosis of non-insulin-dependent diabetes mellitus in these patients. Sex-specific rates showed a female to male ratio of 1.25 to 1. Age-specific rates indicated that non-insulin-dependent diabetes mellitus was most often diagnosed before age 55 and most commonly in the forties.

APA, Harvard, Vancouver, ISO, and other styles

8

Sarayani, Amir, Arash Rashidian, and Kheirollah Gholami. "Low utilisation of diabetes medicines in Iran, despite their affordability (2000–2012): a time-series and benchmarking study." BMJ Open 4, no. 10 (October 2014): e005859. http://dx.doi.org/10.1136/bmjopen-2014-005859.

Full text

Abstract:

ObjectivesDiabetes is a major public health concern worldwide, particularly in low-income and middle-income countries (LMICs). Limited data exist on the status of access to diabetes medicines in LMICs. We assessed the utilisation and affordability of diabetes medicines in Iran as a middle-income country.DesignWe used a retrospective time-series design (2000–2012) and assessed national diabetes medicines’ utilisation using pharmaceuticals wholesale data.MethodsWe calculated defined daily dose consumptions per population days (DDDs/1000 inhabitants/day; DIDs) indicator. Findings were benchmarked with data from Organization for Economic Co-operation and Development (OECD) countries. We also employed Drug Utilization-90% (DU-90) method to compare DU-90s with the Essential Medicines List published by the WHO. We measured affordability using number of minimum daily wage required to purchase a treatment course for 1 month.ResultsDiabetes medicines’ consumption increased from 4.47 to 33.54 DIDs. The benchmarking showed that medicines’ utilisation in Iran in 2011 was only 54% of the median DIDs of 22 OECD countries. Oral hypoglycaemic agents consisted over 80% of use throughout the study period. Regular and isophane insulin (NPH), glibenclamide, metformin and gliclazide were the DU-90 drugs in 2012. Metformin, glibenclamide and regular/NPH insulin combination therapy were affordable throughout the study period (∼0.4, ∼0.1, ∼0.3 of minimum daily wage, respectively). While the affordability of novel insulin preparations improved over time, they were still unaffordable in 2012.ConclusionsThe utilisation of diabetes medicines was relatively low, perhaps due to underdiagnosis and inadequate management of patients with diabetes. This had occurred despite affordability of essential diabetes medicines in Iran. Appropriate policies are required to address the underutilisation of diabetes medicines in Iran.

APA, Harvard, Vancouver, ISO, and other styles

9

Morovatdar, Negar, Gholamreza Tayebi Nasrabad, Konstantinos Tsarouhas, and Ramin Rezaee. "Etiology of Renal Replacement Therapy in Iran." International Journal of Nephrology 2019 (November 26, 2019): 1–5. http://dx.doi.org/10.1155/2019/5010293.

Full text

Abstract:

Introduction. End-stage renal disease (ESRD) is one of the most common life-threatening diseases. In the past two decades, several factors were held responsible as the cause of this condition. The present study aimed to determine the causes of ESRD in the province of Khorasan Razavi, Iran. Materials and Methods. This cross-sectional study was conducted on 2404 ESRD patients who referred to 39 hemodialysis centers in Khorasan Razavi province, Iran, and were registered in the Mashhad University of Medical Sciences (MUMS), between 2000 and December 2018. Sociodemographic data and causes of ESRD were extracted from data registry. Results. The mean age at onset of hemodialysis for 2404 patients was 52.8 ± 16.4 years, and 57.1% of the patients were male. Clinical profile of hypertension (28.3%) and diabetes mellitus (24.8%) were the most common known causes of ESRD in our patients. Hypertension was more prevalent in male patients compared with females (30 vs 25%, respectively) while diabetes was more prevalent in females compared with males (25.4 vs 24.4%, respectively), p=0.009. Educational level was significantly associated with the cause of ESRD (p<0.001). Age of onset of ESRD in hypertensive patients was significantly lower compared with diabetic patients (51.5 ± 16.3 vs 58.28 ± 12.9 years, respectively; p<0.001). Conclusions. In the current study, the most common causes of ESRD were hypertension and diabetes mellitus. Primary prevention of hypertension and diabetes and proper treatment must be considered to reduce the burden of ESRD in Iran.

APA, Harvard, Vancouver, ISO, and other styles

10

Azizi, F., M. M. Gouya, P. Vazirian, P. Dolatshahi, and S. Habibian. "The diabetes prevention and control programme of the Islamic Republic of Iran." Eastern Mediterranean Health Journal 9, no. 5-6 (March 31, 2003): 1114–21. http://dx.doi.org/10.26719/2003.9.5-6.1114.

Full text

Abstract:

Diabetes mellitus has become a monumental problem and a major health concern throughout the world. We report on the programme developed by the Islamic Republic of Iran for control and management of diabetes, which involves screening for type 2 diabetes in adults at risk and a systematic approach for delivery of health care to people with diabetes

APA, Harvard, Vancouver, ISO, and other styles

11

Masoudi Alavi, Negin, Fazllolah Ghofranipour, Fazllolah Ahmadi, Gholamreza Babaee, Assadollah Rajab, and Azita Emami. "Explanatory Model of Diabetes Management; An Experience From Iran." Nursing and Midwifery Studies 1, no. 2 (December 20, 2012): 100–6. http://dx.doi.org/10.5812/nms.8675.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Ebrahimipour, Hossein, Zahra Keyvanlo, Hamid Heidarian Miri, Mehdi Yousefi, Mehdi Ariafar, Alireza Rezazadeh, and Elahe Pourahmadi. "Productivity Loss of Diabetes in Iran (South Khorasan Province)." Journal of Research & Health 11, no. 6 (December 1, 2021): 403–12. http://dx.doi.org/10.32598/jrh.11.6.1780.1.

Full text

Abstract:

Background: This study aims to assess the productivity loss in diabetic patients living in South Khorasan Province, Iran, in 2017. Methods: This cost of illness and analytical study was performed on 1003 patients with diabetes referred to hospitals and healthcare centers in South Khorasan Province. After being randomly selected, the participants filled the short form health and labor questionnaire by the human capital method to estimate the productivity loss caused by health problems. Data were collected in person or via phone interviews. The collected data were analyzed by data quantile regression model using Stata v. 11. Results: The Mean±SD productivity loss based on actual and labor law income was 19.61±46.24 and 16.61±49.39 dollars, respectively. In addition, the results showed that the Mean±SD number of lost working days is 0.81±2.39 days. According to the regression model, gender, educational levels, marital status, and employment status affected the number of working days lost at 0.25 quantile (P≤0.05). Conclusion: Improving productivity in diabetic patients and consequently reducing the resulting economic burden is essential to promoting their physical, mental, and social health.

APA, Harvard, Vancouver, ISO, and other styles

13

Molayaghobi, Nasrin Soltani, Parvaneh Abazari, Fariba Taleghani, and Bijan Iraj. "Diabetes management challenges in Iran: A qualitative content analysis." Journal of Nursing Management 27, no. 6 (May 14, 2019): 1091–97. http://dx.doi.org/10.1111/jonm.12777.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Rasolabadi, Masoud, Shahnaz Khaledi, Marlin Ardalan, Marya Kalhor, Susan Penjvini, and Alireza Gharib. "Diabetes Research in Iran: a Scientometric Analysis of Publications Output." Acta Informatica Medica 23, no. 3 (2015): 160. http://dx.doi.org/10.5455/aim.2015.23.160-164.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Bay, Vahid, Naser Darakhshani, Fatemeh Bay, Ehsan Zarei, Mahboobeh Asadzadeh, and Saeed Fallah. "Quality of diabetes care and its consequences in Northern Iran." Clinical Diabetology 10, no. 6 (December 28, 2021): 462–67. http://dx.doi.org/10.5603/dk.2021.0051.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Baradaran, Hamid R., Narges Shams-Hosseini, Somayeh Noori-Hekmat, Arash Tehrani-Banihashemi, and Mohammad E. Khamseh. "Effectiveness of Diabetes Educational Interventions in Iran: A Systematic Review." Diabetes Technology & Therapeutics 12, no. 4 (April 2010): 317–31. http://dx.doi.org/10.1089/dia.2009.0118.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Ziaei-Rad, Marzieh, Mariam Vahdaninia, and Ali Montazeri. "Sexual dysfunctions in patients with diabetes: a study from Iran." Reproductive Biology and Endocrinology 8, no. 1 (2010): 50. http://dx.doi.org/10.1186/1477-7827-8-50.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Doosti-Irani, Mehri, Samereh Abdoli, Soroor Parvizy, and Naimeh Seyed Fatemi. "Overcoming diabetes-related stigma in Iran: A participatory action research." Applied Nursing Research 36 (August 2017): 115–21. http://dx.doi.org/10.1016/j.apnr.2017.06.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Keshavarz, Maryam, N. Wah Cheung, Gholam Reza Babaee, Hamid Kalalian Moghadam, Mohammad Esmail Ajami, and Mohammad Shariati. "Gestational diabetes in Iran: incidence, risk factors and pregnancy outcomes." Diabetes Research and Clinical Practice 69, no. 3 (September 2005): 279–86. http://dx.doi.org/10.1016/j.diabres.2005.01.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Asl, Samaneh Noroozi, Rahim Vakili, Saba Vakili, Fahimeh Soheilipour, Mahin Hashemipour, Sara Ghahramani, Elisa De Franco, and Hanieh Yaghootkar. "Wolcott-Rallison syndrome in Iran: a common cause of neonatal diabetes." Journal of Pediatric Endocrinology and Metabolism 32, no. 6 (June 26, 2019): 607–13. http://dx.doi.org/10.1515/jpem-2018-0434.

Full text

Abstract:

Abstract Background Wolcott-Rallison syndrome is a rare autosomal recessive disorder characterized by neonatal/early-onset non-autoimmune insulin-dependent diabetes, multiple epiphyseal dysphasia and growth retardation. It is caused by mutations in the gene encoding eukaryotic translation initiation factor 2α kinase 3 (EIF2AK3). We aimed to study the clinical characteristics and frequency of the disease in the Iranian population. Methods We recruited 42 patients who referred to the endocrine and metabolism clinic at Mashhad Imam Reza Hospital with neonatal diabetes. Molecular screening of KCNJ11, INS, ABCC8 and EIF2AK3 was performed at the Exeter Molecular Genetics Laboratory, UK. We calculated the frequency of the disease in 124 patients referred from Iran to the Exeter Molecular Genetics Laboratory for genetic screening and compared it to other countries worldwide. Results We identified seven patients as having Wolcott-Rallison syndrome. Genetic testing confirmed the clinical diagnosis and indicated five novel mutations. Only two patients developed clinical features of the syndrome by 6 months of age. Of all 124 cases of Iranian neonatal diabetes referred to the Exeter Molecular Genetics Laboratory for genetic screening, 28 patients (22.58%) had a recessive mutation in EIF2AK3. Conclusions The results of this study raises awareness of the condition and provides further accurate data on the genetic and clinical presentation of Wolcott-Rallison syndrome in the Iranian population. Our study highlights the importance of genetic testing in patients from consanguineous families with diabetes diagnosed within the first 6 months of life.

APA, Harvard, Vancouver, ISO, and other styles

21

Sharifzadeh, Gholam Reza, DJavad Ghoddoosi-Nejad, Susan Behdani, Elaheh Haghgoshayie, Yibeltal Siraneh, and Edris Hasanpoor. "Diabetes patients’ perspectives on the patients’ rights: evidence from east of Iran." International Journal of Human Rights in Healthcare 12, no. 4 (August 29, 2019): 276–84. http://dx.doi.org/10.1108/ijhrh-09-2018-0060.

Full text

Abstract:

Purpose The Iranian patients’ rights charter defines patient rights as a reflection of fundamental human rights in the field of medicine and incorporates all elements of patient rights accepted in international texts. The purpose of this paper is to study the way in which diabetes patients’ rights are being exercised in everyday hospital practice in Birjand, Iran. Design/methodology/approach A cross-sectional study design was used in 2014. The sample size was estimated 150 patients, out of which 108 diabetes patients completed questionnaire. The questionnaire of diabetes patients’ perspectives on the patients’ rights was used to collect data. The questionnaire consists of 22 questions. Data entry and analysis were carried out using SPSS software (version 22). Descriptive and inferential statistics were calculated with all survey items and total scores, as well as demographic data. Findings The response rate was 72 percent. Overall, the mean score percentage of diabetes patients’ perspectives on the patients’ rights was 74.04± 8.4. Furthermore, statistical significant differences were found among diabetes patients in relation to patients’ perspectives on the patients’ rights according to highest level of education (F=16.52, p=0.002), their habitat(t=3.49, p=0.001), age groups (F=18.70, p=0.0001) and the duration of the disease (F=5.16, p=0.007). The results showed that no statistically significant differences were observed among diabetes patients in relation to diabetes patients’ perspectives on the patients’ rights according to their gender (F=1.57, p=0.12) and marital status (F=1.56, p=0.09). Originality/value Clinicians can provide care based on patients’ rights, and their knowledge of patients’ rights needs to be evaluated. Educational courses, leaflets, booklets and posters can be helpful in this regard. In addition, professional organizations and the Ministry of Health need to be more sensitive to this issue.

APA, Harvard, Vancouver, ISO, and other styles

22

Zamanfar, Daniel, Mohsen Aarabi, Monireh Amini, and Mahila Monajati. "Prevalence of autoantibodies in type 1 diabetes mellitus pediatrics in Mazandaran, North of Iran." Journal of Pediatric Endocrinology and Metabolism 33, no. 10 (August 17, 2020): 1299–305. http://dx.doi.org/10.1515/jpem-2019-0396.

Full text

Abstract:

AbstractObjectivesType 1 diabetes is an autoimmune disease. Its most important immunologic markers are pancreatic beta-cell autoantibodies. This study aimed to determine diabetes mellitus antibodies frequency among children and adolescents with type 1 diabetes.MethodsThis descriptive study evaluated the frequency of four diabetes autoantibodies (glutamic acid decarboxylase 65 autoantibodies [GADA], islet cell autoantibodies [ICA], insulin autoantibodies [IAA], tyrosine phosphatase–like insulinoma antigen-2 antibodies [IA-2A]) and their serum level in children and adolescents diagnosed with type 1 diabetes mellitus at the diabetes department of Bou-Ali-Sina Hospital and Baghban Clinic, Sari, Iran, from March 2012 to March 2018. The relationship between the level of different antibodies and age, gender, and diabetes duration were determined. A two-sided p value less than 0.05 indicated statistical significance.ResultsOne hundred forty-two eligible patient records were screened. The average age at diabetes diagnosis was 4.2 ± 4.4 years. The median duration of diabetes was 34.0 (12.7–69.7) months. 53.5% of patients were female, and 81.7% of them had at least one positive autoantibody, and ICA in 66.2%, GADA in 56.3%, IA-2A in 40.1%, and IAA in 21.8% were positive. The type of the autoantibodies and their serum level was similar between females and males but there was a higher rate of positive autoantibodies in females. The level of IA-2A and ICA were in positive and weak correlation with age at diagnosis.ConclusionsMore than 80% of pediatric and adolescent patients with type 1 diabetes were autoantibody-positive. ICA and GADA were the most frequently detected autoantibodies. The presence of antibodies was significantly higher in females.

APA, Harvard, Vancouver, ISO, and other styles

23

Shahraz, Saeid, Sahar Saeedi Moghaddam, Mehrdad Azmin, Niloofar Peykari, Moein Yoosefi, Farnam Mohebi, Shahab Khatibzadeh, et al. "Prevalence of Diabetes and Prediabetes, and Achievements in Diabetes Control in Iran; The Results of the STEPS of 2016." Archives of Iranian Medicine 25, no. 9 (September 1, 2022): 591–99. http://dx.doi.org/10.34172/aim.2022.94.

Full text

Abstract:

Background: Using the WHO STEPwise approach to NCD risk factor surveillance (STEPS), first round of Iran’s STEPS completed in 2005. It has been repeated six times afterward. Here we report the results of 2016 round on the population characteristics and prevalence of diabetes and prediabetes, along with an assessment of the country-level performance on diabetes care in Iran. Methods: Using a proportional-to-size cluster random sampling method, the STEPS 2016 included 18947 subjects aged≥25 years who matched the criteria (non-missing information on diabetes self-report, and biomarkers). For the analyses, survey design methods with weighted samples were employed. Different definitions of diabetes (biomarker-based, self-report, anti-diabetes medication use, or a combination) and prediabetes (different cutpoints of the biomarker) were calculated and presented. Results: An estimated 5171035 persons aged≥25 years or 10.6% (95% CI: 10.0%–11.1%) had diabetes according to the serologic diagnosis of diabetes (FPG≥126 mg/dL) or the use of at least one anti-diabetes medication (1896 out of 18947). Employing the serologic diagnosis of diabetes among those who responded no to the self-reported question, 2.7% (2.5%–3.0%) of the population were not aware of their diabetes compared to 11.5% (10.9%-12.0%) who were diabetics according to the just self-reported question. Defining prediabetes as 100≤FPG<126 mg/dL or 5.7≤HbA1c<6.5%, an estimated 15244299 persons had prediabetes (5885 out of 18947). Overall, 52.1% (49.4%–54.7%) of patients with self-reported diabetes were under strict glycemic control (HbA1c<7%). Poor diabetes control (HbA1c>9%) was found in 18.4% (16.3%-20.6%) of the patients with self-reported diabetes. Conclusion: Since 2005, the prevalence of diabetes in Iran has been on a gradual increase in both genders with an increasing gap between females and males.

APA, Harvard, Vancouver, ISO, and other styles

24

Sotoudehfar, Masoud, Zahra Mazloum Khorasani, Zahra Ebnehoseini, Kobra Etminani, Mahmoud Tara, and Robab bigom Aboutorabi. "DETERMINING THE MINIMUM DATA SET FOR DIABETES REGISTRY." Medical Technologies Journal 1, no. 4 (November 29, 2017): 115–16. http://dx.doi.org/10.26415/2572-004x-vol1iss4p115-116.

Full text

Abstract:

Introduction: The number of people with diabetes's increasing. More than 220 million people have diabetes, more than 70% of whom live in middle and lower-income countries. already exist many innovations around the world on improving the managed care of diabetes .diabetes registries are one of them. in Iran, development and evaluation of diabetes information systems is one of the most research priorities. since defining health regulations and evaluation of diabetes prevention programs depend on the powerful information system, but in Iran don't exist complete information about incidence and prevalence of diabetes. determine standard data elements (Des) and design diabetes registry is one the most important country requirements. the main purpose of this study is investigating to this subject. Methods: This is a descriptive- analytic study. Resource related to diabetes DEs collected from selective minimum data sets. Then diabetes DEs set derived from selective minimum data sets were investigated in focus group sessions with endocrine specialists, health informatics, and health information management. Duplicate DEs were removed and similar DEs were combined. Then seven endocrine specialists evaluated diabetes DEs set. They determine the value of each DEs using the Delphi technique (scores range from 0 to 5). The DEs that received more than 75% of grade 4 and 5 remained in the study. Following the expert opinion, the final version of the diabetes DEs set was designed. Results: According to literature review 455 DEs included studying, after Delphi sessions, 293 data element remained to study. Main categories of DEs are:1-patient demographic characterizes (12 DEs), 2-patient referral (5 DEs), 3-diabetes care follow up (15 DEs), 4-physical exam, chief complaint and assessment (40 DEs), 5-history (such as: individual, grow up, family, drug abuse) (10 DEs), 6-pregnancy management (13 DEs), 7-screening (10 DEs), 8-specialty evolutions ( such as: cardiovascular (18 DEs), neuropathy (16 DEs), nephropathy (7 DEs), teeth and mouse (3 DEs), eyes (14 DEs), psychology situation (2 DEs), sexual ability (1 DEs)), 9-laboratory exams (33 DEs), 10-drugs (oral antidiabetics drugs (14 DEs), injectable antidiabetics (7 DEs), lipid (11 DEs), hypertension (20 DEs), anti placates (2 DEs)), cardiac (3 DEs), preparing insulin method (5 DEs)), 11-physical activity (4 DEs),12- diet (12 DEs), 13-education and self care (13 DEs). Conclusion: In the study diabetes, DEs set were determined that provide appropriate yield for data gathering and record all required information for diabetes care. Hence diabetes is a chronic disease and Patients suffer from it for years, implementation diabetes DEs can improve documentation and improve diabetes care.

APA, Harvard, Vancouver, ISO, and other styles

25

Zoghi, Ghazal, and Masoumeh Kheirandish. "Prevalence of Type 2 Diabetes, Obesity, Central Obesity, and Metabolic Syndrome in a South Coastal Region, Iran, the PERSIAN Bandare Kong Cohort Study: A Brief Report." Hormozgan Medical Journal 25, no. 1 (November 28, 2020): 42–44. http://dx.doi.org/10.34172/hmj.2021.109599.

Full text

Abstract:

Background: There has been no recent estimate of non-communicable diseases (NCDs) in south of Iran. Our data are based on the results of the population-based Bandare Kong Cohort Study, as part of the Prospective Epidemiological Research Studies in IrAN (PERSIAN). Methods: In this cohort, 4063 people aged 35-70 years were recruited from Hormozgan province, South of Iran. Results: We found that the age-standardized prevalence (ASP) of metabolic syndrome (MetS), type 2 diabetes (T2DM), impaired fasting glucose (IFG), obesity, and central obesity in this population were 34.5%, 17.4%, 20.6%, 24.6%, and 44.4%, respectively. Conclusion: These results give a new insight into the prevalence of the NCDs in a sample population from south of Iran and provide the authorities with the necessary information to design guidelines for the control and prevention of these diseases.

APA, Harvard, Vancouver, ISO, and other styles

26

Khazaei, Zaher, Malihe Sohrabivafa, and Abolfazl Marvi. "Diabetes mellitus as a public health problem; a mini-review on the occasion of world diabetes day 2018 with regard to nephrology." Journal of Nephropharmacology 7, no. 2 (June 2, 2018): 80–82. http://dx.doi.org/10.15171/npj.2018.18.

Full text

Abstract:

Type II diabetes is predominantly preventable and managing diabetes by using standard protocols and measures such as promoting healthy living, self-care education in patients, regular screening, with the aim of early diagnosis of disease and its treatment is necessary. These modalities can potentially prevent complications and premature death due to diabetes. Therefore, according to increasing prevalence of diabetes in Iran, along with the growth of aging and lifestyle changes towards urbanization and inactivity, it is necessary to plan for the prevention, care and screening of diabetes in rural areas, especially in the cities, which still have a large proportion of unknown patients.

APA, Harvard, Vancouver, ISO, and other styles

27

Bandarian, Fatemeh, and Bagher Larijani. "World diabetes day: celebrating two decades of Progress in combating diabetes and its complications in Iran." Journal of Diabetes & Metabolic Disorders 18, no. 2 (November 26, 2019): 743–45. http://dx.doi.org/10.1007/s40200-019-00470-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Aalaa, Maryam, Mohammadreza Amini, Hossein Yarmohammadi, Hamid Reza Aghaei Meybodi, Mostafa Qorbani, Hossien Adibi, Faride Razi, Neda Mehrdad, and Mahnaz Sanjari. "Diabetic foot self-care practice in women with diabetes in Iran." Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15, no. 5 (September 2021): 102225. http://dx.doi.org/10.1016/j.dsx.2021.102225.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

JANGHORBANI, Mohsen, Masoud AMINI, and Aliakbar TAVASSOLI. "Coronary heart disease in type 2 diabetes melittus in Isfahan, Iran." Acta Cardiologica 61, no. 1 (February 1, 2006): 13–20. http://dx.doi.org/10.2143/ac.61.1.2005135.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Hadaegh, Farzad, Maryam Tohidi, Hadi Harati, Maryam Kheirandish, and Shafei Rahimi. "PREVALENCE OF GESTATIONAL DIABETES MELLITUS IN SOUTHERN IRAN (BANDAR ABBAS CITY)." Endocrine Practice 11, no. 5 (September 2005): 313–18. http://dx.doi.org/10.4158/ep.11.5.313.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Soleymani, F., A. Farshchi, and M. Haerizadeh. "PDB69 Prescription Pattern Study of Type 2 Diabetes Mellitus in Iran." Value in Health 14, no. 7 (November 2011): A484. http://dx.doi.org/10.1016/j.jval.2011.08.1372.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Javanbakht, Mehdi, Hamid R. Baradaran, Atefeh Mashayekhi, Ali Akbar Haghdoost, Mohammad E. Khamseh, Erfan Kharazmi, and Aboozar Sadeghi. "Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in Iran." PLoS ONE 6, no. 10 (October 31, 2011): e26864. http://dx.doi.org/10.1371/journal.pone.0026864.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Soveid, Mahmood, Ali Reza Serati, and Masoomeh Masoompoor. "Incidence of hip fracture in Shiraz, Iran." Osteoporosis International 16, no. 11 (April 19, 2005): 1412–16. http://dx.doi.org/10.1007/s00198-005-1854-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Gholami, Soraya, Mahin Kamalifard, Niloufar Sattarzadeh Jahdi, Jalil Babapour, and Foad Yousefi. "The Correlation Between Sexual Dysfunction and Marital Dissatisfaction in Women With Type 2 Diabetes Mellitus: A Cross-sectional Study." Crescent Journal of Medical and Biological Sciences 9, no. 2 (April 22, 2022): 93–97. http://dx.doi.org/10.34172/cjmb.2022.16.

Full text

Abstract:

Objectives: The prevalence of sexual dysfunction and marital dissatisfaction is higher in women with type 2 diabetes mellitus than in the general population. However, the correlation between sexual dysfunction and marital dissatisfaction in diabetic women is debated. The present study investigated the correlation between sexual dysfunction and sexual dissatisfaction in diabetic women. Materials and Methods: In this cross-sectional study, 126 women with type 2 diabetes mellitus, referring to Sanandaj Diabetes Center, Sanandaj, Iran, were compared to 126 randomly selected non-diabetic women referring to Health Centers of Sanandaj, Iran. Women’s sexual function was appraised through the female sexual function index (FSFI), and their marital satisfaction was compared using ENRICH (Evaluation and Nurturing Relationship Issues, Communication and Happiness) Marital Satisfaction Scale. Results: There was a positive significant relationship between sexual function and marital satisfaction (P<0.01, r = 0.675) in diabetic women. In other words, marital satisfaction improved sexual function increases. Conclusions: Marital satisfaction in diabetic women with sexual dysfunction is more unfavorable than in healthy women. Therefore, maximum attention should be paid to the role of sexual dysfunction in the marital relationship of people with diabetes mellitus.

APA, Harvard, Vancouver, ISO, and other styles

35

Ghassemi, Hossein, Gail Harrison, and Kazem Mohammad. "An accelerated nutrition transition in Iran." Public Health Nutrition 5, no. 1a (February 2002): 149–55. http://dx.doi.org/10.1079/phn2001287.

Full text

Abstract:

Abstract:Objective:To describe the emergence of the nutrition transition, and associated morbidity shifts, in the Islamic Republic of Iran.Design:Review and analysis of secondary data relating to the socio-political and nutritional context, demographic trends, food utilisation and consumption patterns, obesity, and diet-related morbidity.Results and conclusions:The nutrition transition in Iran is occurring rapidly, secondary to the rapid change in fertility and mortality patterns and to urbanisation. The transition is occurring against the backdrop of lack of sustained economicgrowth. There is considerable imbalance in food consumption with low nutrient density characterising diets at all income levels, over-consumption evident among more than a third of households, and food insecurity among 20% of the population. Obesity is an emerging problem, particularly in urban areas and for women, and both diabetes and other risk factors for heart disease are becoming significant problems.

APA, Harvard, Vancouver, ISO, and other styles

36

Doosti-Irani, Mehri, Kobra Noorian, and Samereh Abdoli. "Exploring the strategies to overcome diabetes-related stigma in patients’ family: A qualitative study." Journal of Research in Clinical Medicine 10 (September 7, 2022): 16. http://dx.doi.org/10.34172/jrcm.2022.016.

Full text

Abstract:

Introduction: Asian countries, including Iran, experience diabetes-related stigma. Since a stigma-free identity is necessary for optimal diabetes management, the necessity of efforts to reduce diabetes-related stigma has been emphasized. This study aimed to explore the strategies to overcome diabetes-related stigma at the family level in Iran. Methods: Seventy-four volunteered people (people with diabetes, family members, non-diabetic people, and healthcare personnel) participated in a qualitative content analysis study to extract the anti-stigma strategies. Data collection was done until data saturation through unstructured in-depth face-to-face interviews, focus groups, Email, short message service (SMS), and telephone interviews. All audio-recorded and transcribed verbatim data were analyzed using the conventional content analysis approach. Results: Participants were raised "empowering families of people with diabetes" that would be possible through "family education" and "family-group formation". Educating families about "stigmatizing behavior", "coping skills", "accepting the person with diabetes as the main responsible person for disease control", and "diabetes" is necessary to help families by creating a free-stigma atmosphere. All the training could be programmed in peer groups of families to facilitate goal achievement. Conclusion: Some obtained strategies have been suggested for other stigmatizing conditions like tuberculosis or mental health. However, it must be noticed that every condition is specific and also each stigmatized person is unique and is affected by complex factors. So it is impossible to develop generic stigma reduction interventions for all health conditions. Most studies on stigma have considered families a part of society and have proposed general strategies for them.

APA, Harvard, Vancouver, ISO, and other styles

37

Azizi, F., M. M. Guoya, P. Vazirian, P. Dolatshati, and S. Habbibian. "Screening for type 2 diabetes in the Iranian national programme: a preliminary report." Eastern Mediterranean Health Journal 9, no. 5-6 (March 31, 2003): 1122–27. http://dx.doi.org/10.26719/2003.9.5-6.1122.

Full text

Abstract:

Diabetes mellitus is a significant threat to public health. It is estimated that more than 1.5 million people with diabetes live in the Islamic Republic of Iran. We report on the preliminary results of the national programme for the prevention & control of type 2 diabetes which began in 1996. The pilot project has so far been instituted in 17 provinces. Of 595 717 people aged 30 years and over, 247 518 were classed as at risk and 3.6% had diabetes, 4.3% of women and 2.6% of men. Diabetes prevalence varied from 1.3% in rural areas to 14.5% in large cities. Early detection and control strategies are aimed at diminishing the heavy burden of diabetes

APA, Harvard, Vancouver, ISO, and other styles

38

Sadeghi, Masoumeh, Hamidreza Roohafza, Shahin Shirani, Masoud Poormoghadas, Roya Kelishadi, Abdolmehdi Baghaii, and Nizal Sarraf-Zadegan. "Diabetes and Associated Cardiovascular Risk Factors in Iran: The Isfahan Healthy Heart Programme." Annals of the Academy of Medicine, Singapore 36, no. 3 (March 15, 2007): 175–80. http://dx.doi.org/10.47102/annals-acadmedsg.v36n3p175.

Full text

Abstract:

Introduction: Diabetes mellitus (DM) is one of the major health problems worldwide. The aim of this study was to detect the prevalence of DM and its associated risk factors in Iran. Materials and Methods: This cross-sectional study was performed in 3 cities in the central part of Iran on participants over the age of 19 years. Sampling was conducted by multi-stage randomised cluster method. Initially, a questionnaire consisting of demographic information, drug intake and smoking status was filled out. Later, a physical examination was performed, including the measurement of systolic blood pressure (SBP) and diastolic blood pressure (DBP), body mass index (BMI) and waist-to-hip ratio (WHR). Fasting blood sample was drawn and analysed for sugar, total cholesterol (TC), triglyceride (TG) and 2-hour postprandial glucose. A fasting blood sugar (FBS) of >126 mg/dL or a 2-hour plasma glucose of over 200 mg/dL was considered an indication of diabetes. The impaired glucose tolerance test (IGTT) was defined with 2-hour plasma glucose of 140 to 200 mg/dL and FBS <126 mg/dL. The collected data were analysed with Student’s t-test, chi-square test and multiple logistic regression analysis. Results: This study was performed on 12,514 subjects (48.9% males and 51.1% females). The total prevalence of DM was 6.7% and 5.3% in urban and rural areas and 5.4% and 7.1% in males and females, respectively. The mean blood glucose rose with age in both sexes, and blood glucose was higher in females and in urban areas. IGTT, known and new DM heightens as age increased and more than half of the diabetes cases in all age groups were newly diagnosed. The mean blood pressure, age, BMI, waist circumference and serum lipids were higher in people with DM and IGTT especially in females. Obesity, a family history of DM, high blood pressure, high WHR and ageing were associated with a higher probability of DM, but sex had no effect on this probability. Discussion and Conclusion: Considering the high prevalence of DM in the central regions of Iran, providing vast educational programme to prevent this disease is essential and screening FBS tests, especially for obese subjects and those with a family history of DM, should be taken into account. Key words: Diabetes mellitus, Glucose tolerance test, Iran, Prevalence, Risk factor

APA, Harvard, Vancouver, ISO, and other styles

39

Shafiee, Gita, Ramin Heshmat, Afshin Ostovar, Iraj Nabipour, and Bagher Larijani. "Sarcopenia disease in Iran: an overview." Journal of Diabetes & Metabolic Disorders 18, no. 2 (November 15, 2019): 665–74. http://dx.doi.org/10.1007/s40200-019-00452-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Bay, Vahid, Irvan Masoudi Asl, Alireza Mahdavi Hezaveh, Mahboobeh Asadzadeh, Alireza Heidari, and Elaheh Yazarloo. "Factors associated with control of type 2 diabetes mellitus in North Iran." Clinical Diabetology 9, no. 6 (December 30, 2020): 426–32. http://dx.doi.org/10.5603/dk.2020.0061.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Shakibazadeh, Elham, Leona Kay Bartholomew, Arash Rashidian, and Bagher Larijani. "Persian Diabetes Self-Management Education (PDSME) program: evaluation of effectiveness in Iran." Health Promotion International 31, no. 3 (March 11, 2015): 623–34. http://dx.doi.org/10.1093/heapro/dav006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Tabrizi, Reza, Zatollah Asemi, Kamran B. Lankarani, Maryam Akbari, Seyed Reza Khatibi, Ahmad Naghibzadeh-Tahami, Mojgan Sanjari, et al. "Gestational diabetes mellitus in association with macrosomia in Iran: a meta-analysis." Journal of Diabetes & Metabolic Disorders 18, no. 1 (February 21, 2019): 41–50. http://dx.doi.org/10.1007/s40200-019-00388-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Sajady, F., N. SarrafZadegan, H. Alikhasih, N. Mohammadifard, and N. Abdar. "Prevalence of non insulin dependent diabetes millitus during 1976–1997 in Iran." Atherosclerosis 151, no. 1 (July 2000): 67. http://dx.doi.org/10.1016/s0021-9150(00)80306-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Esteghamati, A., O. Khalilzadeh, M. Anvari, A. Meysamie, M. Abbasi, M. Forouzanfar, and F. Alaeddini. "The economic costs of diabetes: a population-based study in Tehran, Iran." Diabetologia 52, no. 8 (May 28, 2009): 1520–27. http://dx.doi.org/10.1007/s00125-009-1398-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Noshad, Sina, Mohsen Afarideh, Behnam Heidari, Jeffrey I. Mechanick, and Alireza Esteghamati. "Diabetes Care in Iran: Where We Stand and Where We Are Headed." Annals of Global Health 81, no. 6 (April 22, 2016): 839. http://dx.doi.org/10.1016/j.aogh.2015.10.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Moradinazar, Mehdi, Yahya Pasdar, Farid Najafi, Ebrahim Shakiba, Behrooz Hamzeh, Mehnoosh Samadi, Maryam Mirzaei, and Annette J. Dobson. "Validity of self-reported diabetes varies with sociodemographic charecteristics: Example from Iran." Clinical Epidemiology and Global Health 8, no. 1 (March 2020): 70–75. http://dx.doi.org/10.1016/j.cegh.2019.04.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Baradaran Binazir, Maryam, and Fariba Heidari. "Letter to Editor: Positive predictive value of diabetes mellitus risk assessment." Journal of Research & Health 12, no. 1 (March 6, 2022): 1. http://dx.doi.org/10.32598/jrh.12.1.1940.1.

Full text

Abstract:

Diabetes mellitus (DM) is an important public health challenge [1 ].Different studies predicted that the frequency of diabetic patients will be increased to 642 million throughout the world by 2040 [2]. A notable percentage of diabetic patients are not aware of their disease (approximately 30% in Iran) [3]. Lag in the diagnosis of DM raises the expense of controlling disease and makes the prognosis poorer [4]. It is indicated the importance of diabetic risk assessment as a screening test for high risk populations. However, most of the screening methods to detect high risk people are invasive [5]. So, detecting population at high risk of developing DM by an easy way that can be applied by health care providers in the health centers may lead to preventive measures of public health magnitude [4]. Griffin et al developed a questionnaire according to the risk factors commonly collected in clinical practice and evaluated the characteristics of the questionnaire. They reported the positive predictive value of 11% for diabetes screening questionnaire in England and Wales [6].In Iran, primary health care providers in rural regions were named “Behvarz”. They were performed diabetes mellitus risk assessment as a screening program in health houses. They worked in “Health House,” which is the small health center in the rural areas of Iran. In the present study, we evaluated DM risk assessment positive predictive value (PPV) on the 30 years and older rural population. The PPV is the probability of the diabetes in a person with a positive risk assessment result ( ) [7]. A cross-sectional study was done in three villages of Bostanabad, one of East Azerbaijan ‘s cities in Iran. Three villages out of more than fifteen hundred villages in the Bostanabad were selected as considered concerns about arranging the population in the villages. In these three villages, Behvarzes performed screening activities for diabetes between March2019 to January2020. Screening for diabetes was regarded for all individuals older than 30 years of age living in chosen villages. Participants were interviewed and asked the presence of risk factors of DM. Risk factors contained family history of DM, overweight or obesity (BMI>25), already detected pre-diabetes. Among persons took part in screening test, those even with one risk factor were regarded positive and they as soon as were visited by a primary care physician for detection of individuals with unknown DM. The total population of the three villages, namely Saeid abad, Tikmedash and Kordkandy was 5137. More than half of them (57.62%) were more than 30years old in these villages. Out of 1305 people, who had at least one risk factor, 57 persons were diabetics. Accordingly, 57 was true positive .The value of1305 was the sum of true positive and false positive. Calculated positive predictive value was 4.36%. So, the positive predictive value of the risk factor assessment was low. In Conclusion, the ability of the risk factor assessment to predict individuals with DM was quite poor (96% of people with risk factors were not diabetic) and the risk assessment did not work well to identify at risk individuals

APA, Harvard, Vancouver, ISO, and other styles

48

Kazeminia, Mohsen, Nader Salari, and Masoud Mohammadi. "Prevalence of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Iran: A Systematic Review and Meta-Analysis." Journal of Diabetes Research 2020 (September 26, 2020): 1–9. http://dx.doi.org/10.1155/2020/3069867.

Full text

Abstract:

Background. Type 2 diabetes mellitus (DM) is the most common type of DM and accounts for 90% of the cases. One of the most important complications of type 2 DM is cardiovascular complications, which are the most common cause of mortality in patients with DM. Various studies have reported different incidence rates of cardiovascular disease in patients with type 2 DM. However, no comprehensive review of previous studies has been done. This study is aimed at determining the prevalence of cardiovascular disease in patients with type 2 diabetes mellitus in Iran with a systematic review and meta-analysis. Methods. In this review, studies were first extracted searching domestic and international databases including SID, MagIran, IranMedex, IranDoc, Cochrane, Embase, ScienceDirect, Scopus, PubMed, and Web of Science (ISI), published between 2001 and September 2019. The random effects model was adopted for the analysis, and heterogeneity of the extracted studies was investigated with the I2 index. The data collected from the extracted studies were analyzed using a comprehensive meta-analysis (Version 2) software. Results. The prevalence of cardiovascular disease in patients with type 2 DM in Iran in 17 studies with a sample size of 9656 was 37.4% (95% CI: 31.4-43.8). Based on meta-regression, there was a significant difference on the effect of year of conducting the study and sample size with the prevalence of cardiovascular disease in patients with type 2 DM in Iran (p≤0.001). Conclusion. The results of this study indicated that there was a high prevalence rate of cardiovascular disease in patients with type 2 DM in Iran. Therefore, appropriate strategies should be taken to improve this situation and trace and supervise it at all levels, providing feedback to hospitals.

APA, Harvard, Vancouver, ISO, and other styles

49

Sadoughi, Farahnaz, Ali Valinejadi, and Masoud Salehi. "Diabetes knowledge translation status in developing countries: A mixed method study among diabetes researchers in case of Iran." International Journal of Preventive Medicine 7, no. 1 (2016): 33. http://dx.doi.org/10.4103/2008-7802.175992.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Iranparvar-Alamdari, Manouchehr, Hosein Ghorbani Behrooz, and Mostafa Alidousti. "Prevalence of postpartum thyroiditis in women with gestational diabetes mellitus in Ardabil: North West of Iran." International Journal of Scientific Reports 2, no. 6 (June 14, 2016): 116. http://dx.doi.org/10.18203/issn.2454-2156.intjscirep20161877.

Full text

Abstract:

<p class="abstract"><strong>Background:</strong> Gestational diabetes is the most common metabolic disorder during pregnancy and postpartum thyroiditis is a destructive thyroiditis that can cause serious complications for the mother and her child. The purpose of this study was to determine the prevalence of postpartum thyroiditis in women with gestational diabetes.</p><p class="abstract"><strong>Methods:</strong> In this cross-sectional study, 86 cases satisfy inclusion criteria and gestational diabetes mellitus (GDM) and were evaluated for postpartum thyroiditis with thyroid stimulating hormone (TSH), T4, anti-TPO, T3RU tests. The groups with and without thyroiditis were compared and data was analyzed by statistical methods.</p><p class="abstract"><strong>Results:</strong> There were 17 patients (19.8%) with postpartum thyroiditis, of whom 4 patients (23.5%) had hyperthyroidism, 9 patients (52.9%) were in the age group of 21 to 30 years, and 9 patients (52.9%) had a family history of diabetes. Five patients (29.4%) with high anti-TPO level (P=0.022) and mean TSH and anti-TPO respectively, 2.8 (4.8) and 17.2 (35.9).</p><p><strong>Conclusions:</strong> The results showed that higher level of anti TPO titer and family history of diabetes can be associated with a higher rate of postpartum thyroiditis, so it is recommended that postpartum thyroiditis to be examined in women with gestational diabetes who have these mentioned items.</p>

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!